Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Roaming through methodology. XIX. Cost-effectiveness ratios].

F F Rutten1

  • 1Erasmus Universiteit, Institute for Medical Technology Assessment, Rotterdam. f.rutten@bmg.eur.nl

Nederlands Tijdschrift Voor Geneeskunde
|August 5, 2000
PubMed
Summary

Interpreting cost-effectiveness ratios requires understanding they are relative measures comparing interventions. Always consider the chosen alternative and study context for accurate decision-making.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analysis of costs and cost-effectiveness in multinational trials.

Health policy (Amsterdam, Netherlands)·2001
Same author

The cost effectiveness of tapered versus abrupt discontinuation of oral cyclosporin microemulsion for the treatment of psoriasis.

PharmacoEconomics·2001
Same author

Health economics. A bridge over troubled water.

European journal of public health·2001
Same author

The cost of treatment of Alzheimer's disease in The Netherlands: a regression-based simulation model.

PharmacoEconomics·2001
Same author

Cost effectiveness of continuous terbinafine compared with intermittent itraconazole in the treatment of dermatophyte toenail onychomycosis: an analysis of based on results from the L.I.ON. study. Lamisil versus Itraconazole in Onychomycosis.

PharmacoEconomics·2001
Same author

Quality of life and clinical outcome in psoriasis patients using intermittent cyclosporin.

The British journal of dermatology·2001

Area of Science:

  • Health economics
  • Decision analysis
  • Comparative effectiveness research

Context:

  • Cost-effectiveness analysis (CEA) is crucial for healthcare resource allocation.
  • Interpreting CEA findings requires careful consideration of specific study parameters.
  • Understanding the relative nature of cost-effectiveness is vital for accurate assessment.

Purpose:

  • To elucidate key considerations for interpreting cost-effectiveness ratios.
  • To highlight the importance of comparative analysis in cost-effectiveness.
  • To guide appropriate application of cost-effectiveness data in decision-making.

Summary:

  • Cost-effectiveness ratios are relative, not absolute, measures of efficiency.
  • The selection of the comparator significantly influences incremental cost-effectiveness ratios.
  • The context and appropriateness of the study for the decision are critical.

Impact:

  • Improved understanding of CEA interpretation for researchers and policymakers.
  • More accurate and reliable use of cost-effectiveness data in healthcare decisions.
  • Enhanced efficiency in resource allocation through better-informed choices.

Related Experiment Videos